Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Microbiology Resource Announcements
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • Archive
  • Types of Resources
    • Amplicon Sequence Collections
    • Culture Collections/Mutant Libraries
    • Databases and Software
    • Omics Data Sets
    • Other Genetic Resources
    • Genome Sequences
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MRA
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Microbiology Resource Announcements
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Microbiology Resource Announcements
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • Archive
  • Types of Resources
    • Amplicon Sequence Collections
    • Culture Collections/Mutant Libraries
    • Databases and Software
    • Omics Data Sets
    • Other Genetic Resources
    • Genome Sequences
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MRA
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Prokaryotes

Draft Genome Sequence of Chryseobacterium mucoviscidosis sp. nov. Strain VT16-26, Isolated from the Bronchoalveolar Lavage Fluid of a Patient with Cystic Fibrosis

George Tetz, Victor Tetz
George Tetz
aHuman Microbiology Institute, New York, New York, USA
bTGV-Biomed, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for George Tetz
Victor Tetz
aHuman Microbiology Institute, New York, New York, USA
bTGV-Biomed, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/genomeA.01473-17
  • Article
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We report here the draft genome sequence of Chryseobacterium mucoviscidosis VT16-26, a novel bacterium isolated from the lungs of a patient with cystic fibrosis. The genome was composed of 4,403,956 bp and had 36.2% G+C content. We detected 4,048 genes with predicted protein-coding functions, including those associated with antibiotic resistance and virulence.

GENOME ANNOUNCEMENT

The Chryseobacterium genus is composed of Gram-negative, aerobic, nonmotile, and rod-shaped bacteria. The Chryseobacterium species are uncommon human pathogens, predominantly implicated in infections in immunocompromised hospitalized patients with severe underlying diseases (1–3). However, members of the Chryseobacterium family have never been associated with cystic fibrosis. Using combined culture and genetic workflow, we have previously identified the unexplored diversity of bacteria within the human lungs (4–6).

The 16S rRNA gene of Chryseobacterium mucoviscidosis VT16-26, which was isolated from the bronchoalveolar lavage fluid of a patient with cystic fibrosis, was found to possess ≤98% sequence identity with other representatives of Chryseobacterium species. The genome of Chryseobacterium mucoviscidosis VT16-26 was sequenced using the HiSeq 2500 (GA IIx; Illumina, CA), according to the manufacturer’s instructions. A draft genome was assembled using SPAdes (version 3.5.0), with 156-fold average coverage (7).

In total, 255 assembled contigs, which had 4,403,956 bp and a 36.2% G+C content, were annotated using the NCBI Prokaryotic Genome Annotation Pipeline (8). The genome harbors 83 tRNA genes, 7 rRNA and 3 noncoding RNA (ncRNA) operons, and 4,048 protein-coding sequences. We identified the presence of genes conferring resistance to antibiotics, such as vancomycin, bleomycin, teicoplanin, and tetracycline, via its major facilitator superfamily (MFS) efflux pump, as well as multidrug resistance transporters of the ABC, multiantimicrobial extrusion (MATE), and MFS families. Virulence factors, such as hemolysin D, metalloproteases, peptidases, deoxyribonucleases, ribonucleases, alpha-amylase, and adhesins, were identified in the genome.

In comparison with the genome of its closest relative, Chryseobacterium gambrini DSM 18014, the genome of Chryseobacterium mucoviscidosis VT16-26 is smaller (4,841,687 bp versus 4,403,956 bp). An in silico DNA-DNA hybridization (DDH) analysis confirmed that the genomes of Chryseobacterium gambrini DSM 18014 and Chryseobacterium mucoviscidosis VT16-26 belonged to two different species. This was inferred because the Genome-to-Genome Distance Calculator algorithm produced a DDH value of 58.90%, which was well below the threshold value of 70% (9, 10).

Follow-up studies of Chryseobacterium mucoviscidosis VT16-26 and its harbored bacteriophages would enable us to understand its possible pathogenicity and role in cystic fibrosis (11, 12).

Accession number(s).The complete genome sequence has been deposited in the NCBI database under accession no. MVAG00000000.

ACKNOWLEDGMENTS

We thank the Applied Bioinformatics Center (BFX) at the NYU School of Medicine for providing bioinformatics support and helping with the analysis and interpretation of the data.

This work used computing resources at the High Performance Computing Facility (HPCF) of the Center for Health Informatics and Bioinformatics at the NYU Langone Medical Center.

FOOTNOTES

    • Received 27 November 2017.
    • Accepted 29 November 2017.
    • Published 11 January 2018.
  • Copyright © 2018 Tetz and Tetz.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

REFERENCES

  1. 1.↵
    1. Calderón G,
    2. García E,
    3. Rojas P,
    4. García E,
    5. Rosso M,
    6. Losada A
    . 2011. Chryseobacterium indologenes infection in a newborn: a case report. J Med Case Rep 5:10. doi:10.1186/1752-1947-5-10.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Bloch KC,
    2. Nadarajah R,
    3. Jacobs R
    . 1997. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine 76:30–41. doi:10.1097/00005792-199701000-00003.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Deepa R,
    2. Venkatesh KG,
    3. Parveen JD,
    4. Banu ST,
    5. Jayalakshmi G
    . 2014. Myroides odoratus and Chryseobacterium indologenes: two rare isolates in the immunocompromised. Indian J Med Microbiol 32:327–330. doi:10.4103/0255-0857.136592.
    OpenUrlCrossRef
  4. 4.↵
    1. Tetz V,
    2. Tetz G
    . 2017. Draft genome sequence of Bacillus obstructivus VT-16-70 isolated from the bronchoalveolar lavage fluid of a patient with chronic obstructive pulmonary disease. Genome Announc 5:e01754-16. doi:10.1128/genomeA.01754-16.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Tetz G,
    2. Tetz V
    . 2017. Introducing the sporobiota and sporobiome. Gut Pathog 9:38. doi:10.1186/s13099-017-0187-8.
    OpenUrlCrossRef
  6. 6.↵
    1. Tetz G,
    2. Tetz V,
    3. Vecherkovskaya M
    . 2016. Genomic characterization and assessment of the virulence and antibiotic resistance of the novel species Paenibacillus sp. strain VT-400, a potentially pathogenic bacterium in the oral cavity of patients with hematological malignancies. Gut Pathog 8:6. doi:10.1186/s13099-016-0089-1.
    OpenUrlCrossRef
  7. 7.↵
    1. Bankevich A,
    2. Nurk S,
    3. Antipov D,
    4. Gurevich AA,
    5. Dvorkin M,
    6. Kulikov AS,
    7. Lesin VM,
    8. Nikolenko SI,
    9. Pham S,
    10. Prjibelski AD,
    11. Pyshkin AV,
    12. Sirotkin AV,
    13. Vyahhi N,
    14. Tesler G,
    15. Alekseyev MA,
    16. Pevzner PA
    . 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477. doi:10.1089/cmb.2012.0021.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Tatusova T,
    2. DiCuccio M,
    3. Badretdin A,
    4. Chetvernin V,
    5. Ciufo S,
    6. Li W
    . 2013. Prokaryotic Genome Annotation Pipeline. The NCBI handbook, 2nd ed. National Center for Biotechnology Information, Bethesda, MD.
  9. 9.↵
    1. Auch AF,
    2. von Jan M,
    3. Klenk HP,
    4. Göker M
    . 2010. Digital DNA-DNA hybridization for microbial species delineation by means of genome-to-genome sequence comparison. Stand Genomic Sci 2:117–134. doi:10.4056/sigs.531120.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Chun J,
    2. Rainey FA
    . 2014. Integrating genomics into the taxonomy and systematics of the bacteria and archaea. Int J Syst Evol Microbiol 64:316–324. doi:10.1099/ijs.0.054171-0.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Tetz GV,
    2. Ruggles KV,
    3. Zhou H,
    4. Heguy A,
    5. Tsirigos A,
    6. Tetz V
    . 2017. Bacteriophages as potential new mammalian pathogens. Sci Rep 7:7043. doi:10.1038/s41598-017-07278-6.
    OpenUrlCrossRef
  12. 12.↵
    1. Tetz G,
    2. Tetz V
    . 2017. Prion-like domains in phagobiota. Front Microbiol 8:2239. doi:10.3389/fmicb.2017.02239.
    OpenUrlCrossRef
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Draft Genome Sequence of Chryseobacterium mucoviscidosis sp. nov. Strain VT16-26, Isolated from the Bronchoalveolar Lavage Fluid of a Patient with Cystic Fibrosis
George Tetz, Victor Tetz
Genome Announcements Jan 2018, 6 (2) e01473-17; DOI: 10.1128/genomeA.01473-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print
Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Microbiology Resource Announcements article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Draft Genome Sequence of Chryseobacterium mucoviscidosis sp. nov. Strain VT16-26, Isolated from the Bronchoalveolar Lavage Fluid of a Patient with Cystic Fibrosis
(Your Name) has forwarded a page to you from Microbiology Resource Announcements
(Your Name) thought you would be interested in this article in Microbiology Resource Announcements.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Draft Genome Sequence of Chryseobacterium mucoviscidosis sp. nov. Strain VT16-26, Isolated from the Bronchoalveolar Lavage Fluid of a Patient with Cystic Fibrosis
George Tetz, Victor Tetz
Genome Announcements Jan 2018, 6 (2) e01473-17; DOI: 10.1128/genomeA.01473-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • GENOME ANNOUNCEMENT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About MRA
  • Editor in Chief
  • Board of Editors
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Getting Started
  • Submit a Manuscript
  • Author Warranty
  • Ethics
  • Contact Us
  • ASM Author Center

Follow #MRAJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2576-098X